Highlight Therapeutics Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 23
Employees
  • Latest Deal Type
  • Later Stage VC
  • (In Progress)
  • Latest Deal Amount
  • $4.36M
Latest Deal Amount
  • Investors
  • 8

Highlight Therapeutics General Information

Description

Developer of RNA-based immuno-oncology therapies intended to combat cancer. The company's therapies recapitulate the effect of viral infection and enhance the therapeutic effect of drugs, enabling the medical community and patients to promote speedy recovery from tumors.

Contact Information

Website
www.highlighttherapeutics.com
Formerly Known As
Bioncotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Parque Científico Universidad de Valencia
  • Calle Catedrático Agustín Escardino, 9, Paterna
  • 46980 Valencia
  • Spain
+34 961 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Highlight Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC $4.36M 000.00 In Progress Clinical Trials - Phase 2
6. Later Stage VC 05-Feb-2021 000.00 000.00 Completed Clinical Trials - Phase 2
5. Later Stage VC 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC 06-Oct-2016 000.00 Completed Pre-Clinical Trials
3. Grant 01-Jan-2016 00000 000.00 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Jan-2013 $14.4M $14.4M Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2010 Completed Pre-Clinical Trials
To view Highlight Therapeutics’s complete valuation and funding history, request access »

Highlight Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Marisol Quintero Ph.D Chief Executive Officer
Gema Alonso Chief Financial Officer & Vice President of Finance
Mercedes Pozuelo Rubio Ph.D Chief Operating Officer
Ana Megia Co-Founder
Damià Tormo Ph.D Co-Founder & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Highlight Therapeutics Board Members (6)

Name Representing Role Since
Bart Hooland Self Board Member 000 0000
Carlos Paya Ph.D Highlight Therapeutics Chairman 000 0000
Damià Tormo Ph.D Self Co-Founder & Board Member 000 0000
Javier García-Cogorro Highlight Therapeutics Board Member 000 0000
Luc Dochez Droia Oncology Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Highlight Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Highlight Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Columbus Venture Partners Venture Capital Minority 000 0000 000000 0
Advent Life Sciences Venture Capital Minority 000 0000 000000 0
Centro para el Desarrollo Tecnológico Industrial Government 000 0000 000000 0
European Regional Development Fund Other 000 0000 000000 0
Ministerio de Economía, Industria y Competitividad Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial